Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 372 clinical trials
featured
Advanced Head and Neck Squamous Cell Carcinoma

People with head and neck squamous cell carcinoma may be eligible to participate in a research study being conducted by Northwell Health.  

  • 55 views
  • 27 Jun, 2019
  • 1 location
featured
Advanced Head and Neck Squamous Cell Carcinoma

People with head and neck squamous cell carcinoma may be eligible to participate in a research study being conducted by Montefiore Medical Center.  

  • 24 views
  • 20 May, 2019
  • 1 location
featured
Photoimmunotherapy – Head and Neck Squamous Cell Carcinoma

People with head and neck squamous cell carcinoma are asked to participate in a research study being conducted by Northwell Health.  

  • 87 views
  • 20 Feb, 2019
  • 1 location
featured
INDUCE-3 - Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

People with Head and Neck Squamous Cell Carcinoma are asked to participate in a research study being conducted by Montefiore Medical Center.  

carcinoma
squamous cell carcinoma
  • 25 views
  • 01 May, 2020
  • 1 location
featured
A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

  • 612 views
  • 08 Nov, 2020
  • 1 location
Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma

than 35 year, in complete remission 2-4 months after treatment of head and neck squamous cell carcinoma Patients will be randomized after the post-treatment check-up (clinical examination and reference

cancer
squamous cell carcinoma
  • 0 views
  • 23 Feb, 2020
E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck

Recombinant human endostatin adenovirus injection is a novel anti-tumor gene therapy drug. E10A contains a recombinant human endostatin gene with the second-generation recombinant adenovirus as its vector. After transfection tumor cells. E10A expresses human endostatin, which inhibits vascular endothelial cell proliferation and tumor angiogenesis, and blocks tumor blood supply, thereby …

squamous cell carcinoma
paclitaxel injection
neck cancer
head and neck cancer
squamous cell carcinoma of head and neck
  • 0 views
  • 08 Nov, 2020
  • 1 location
Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck: The HYPNO Trial

The aim of the study is to test whether a resource-sparing 4-week, 20-fraction course of accelerated hypofractionated radiotherapy is non-inferior to accelerated radiotherapy delivering 33 fractions over 5.5 weeks in the treatment of patients with Stage I-IV squamous cell carcinoma of the pharynx, larynx and oral cavity with the exception …

cancer of the head
caries
squamous cell carcinoma
cancer
head and neck cancer
  • 15 views
  • 11 Aug, 2019
  • 2 locations
  • 22 views
  • 24 Dec, 2020
  • 42 locations
Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

/M) head and neck squamous cell carcinoma/cancer (HNSCC). This is a randomized, double-blind, adaptive Phase II/III study comparing a combination of GSK3359609 inducible T cell co-stimulatory

metastatic head and neck squamous cell carcinoma
squamous cell carcinoma
carcinoma of oropharynx
human papillomavirus
primary tumor
  • 6 views
  • 17 Jan, 2021
  • 177 locations